je.st
news
Tag: results
10.29.14 -- Multipoint Monitoring System Produces Results At Ammonia Plant
2014-10-28 08:46:07| chemicalonline Home Page
10/29/14Chemical Online Newsletter
Tags: results
system
plant
monitoring
Amgen (AMGN) Q3 2014 Results - Earnings Call Webcast
2014-10-28 06:11:16| Biotech - Topix.net
The following audio is from a conference call that will begin on October 27, 2014 at 17:00 PM ET. The audio will stream live while the call is active, and can be replayed upon its completion.
Tags: results
call
earnings
webcast
Roper Industries (ROP) Stock Experiences Volatility Following Mixed Earnings Results
2014-10-27 20:48:34| Industrial Machines - Topix.net
The company's stock has fluctuated between reaching all time highs and falling below its $152 opening price today with shares currently down 0.56% to $150.34. The radio frequency product manufacturer reported third quarter earnings of $1.54 per diluted share on an adjusted basis, one cent better than analysts were expecting for the period.
Tags: results
stock
industries
mixed
Merck Announces Third-Quarter 2014 Financial Results
2014-10-27 12:00:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. Third-Quarter 2014 Non-GAAP EPS of $0.90, Excluding Certain Items, and GAAP EPS of $0.31 Narrows 2014 Full-Year Non-GAAP EPS Target to $3.46 to $3.50, Excluding Certain Items; Updates 2014 Full-Year GAAP EPS Target to $4.06 to $4.29; Now Expects 2014 Full-Year Revenues to be Between $42.4 Billion and $42.8 Billion Generated Worldwide Sales of $10.6 Billion, a Decrease of 4 Percent, Reflecting Unfavorable Impact of Divested Products, Patent Expiries and Decline in Sales of Hepatitis C Products Increased Sales of Acute Care, Immunology, Diabetes and Animal Health Products FDA Approved KEYTRUDA for the Treatment of Advanced Melanoma in Patients Who Have Progressed after Other Therapies and BELSOMRA for the Treatment of Insomnia KEYTRUDA Received Breakthrough Therapy Designation from the FDA for Patients with Advanced Non-Small Cell Lung Cancer Who Have Progressed Following Platinum-Containing Chemotherapy WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2014. Language: English Contact: MerckMedia:Steve Cragle, 908-423-3461Lainie Keller, 908-236-5036orInvestors:Joe Romanelli, 908-423-5185Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
financial
announces
merck
Avery Dennison announces third quarter results
2014-10-27 06:00:00| Label and Narrow Web Breaking News
The third quarter net sales have grown approximately 4% to $1.56 billion. Including discontinued operations, the company has reported EPS of $0.68 and an adjusted EPS, which includes non-GAAP, continuing operations, of $0.77.
Tags: results
quarter
announces
avery
Sites : [666] [667] [668] [669] [670] [671] [672] [673] [674] [675] [676] [677] [678] [679] [680] [681] [682] [683] [684] [685] next »